Skip to main content
Equibles

UBS Group AG

Position in CERS — Cerus Corp

CIK 1610520 ZURICH, V8
Back to CERS Full portfolio

Position in CERS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,927,479
-$893,343 QoQ
Shares Held
1,002,562
-52.2% QoQ
Ownership
0.497%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 186 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in CERS Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,686,473,125 across 138 Medical Devices names. CERS ranks #47 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
 16,352,420 $697,921,281
2 ABT
Abbott Laboratories
 7,356,093 $667,491,874
3 SYK
Stryker Corp
 1,909,680 $601,243,647
4 MDT
Medtronic plc
 5,551,443 $434,289,383
5 DXCM
Dexcom Inc
 6,065,779 $408,530,211
6 ZBH
Zimmer Biomet Holdings, Inc.
 2,758,615 $237,489,163
7 PEN
Penumbra Inc
 703,822 $222,231,795
8 EW
Edwards Lifesciences Corp
 2,350,656 $212,640,338

All Filings in CERS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,927,479 1,002,562
2026-03-31 $3,820,822 2,099,353
2025-12-31 $2,353,553 1,142,502
2025-09-30 $555,320 349,258
2025-06-30 $390,406 276,885
2025-03-31 $396,385 285,170
2024-12-31 $2,015,861 1,309,002
2024-09-30 $421,664 242,336
2024-06-30 $405,570 230,438
2024-03-31 $659,624 349,008
2023-12-31 $878,004 406,484
2023-09-30 $496,283 306,348
2023-06-30 $800,478 325,398
2023-03-31 $596,449 200,825
2022-12-31 $2,602,263 712,949
2022-09-30 $2,402,758 667,433
2022-06-30 $3,534,920 668,227
2022-03-31 $3,723,576 678,247
2021-12-31 $4,781,878 702,185
2021-09-30 $3,745,654 615,050
2021-06-30 $246,032 41,630
2021-03-31 $1,393,917 231,933
2020-12-31 $1,155,162 166,931
2020-09-30 $2,822,997 450,958
2020-06-30 $2,809,362 425,661
2020-03-31 $595,599 128,086